Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. G.M.P.J. (Gwenny) Verstappen

Research interests

Immunology, Immuno-Pharmacology, Rheumatology, Autoimmune Diseases, Sjögren's Syndrome, Pharmacological Treatment, Clinical Trials

Publicaties

Aberrant B cell receptor signaling responses in circulating double-negative 2 B cells from radiographic axial spondyloarthritis patients

B Cell Receptor Repertoire Analysis of the CD21lo B Cell Compartment in Healthy Individuals, Patients With Sjögren's Disease, and Patients With Radiographic Axial Spondyloarthritis

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)

Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren's disease

Abatacept use for 24 weeks has a limited effect on salivary gland inflammation in Sjögren's disease patients

A future for prediction and treatment of Sjögren's disease-associated lymphomas

Highlights of the 16th International Symposium for Sjögren's Disease

Histopathological comparison of Sjögren-related features between paired labial and parotid salivary gland biopsies of sicca patients

IL-17 is associated with disease severity and targetable inflammatory processes in heart failure

Increased diagnostic accuracy of the labial gland biopsy in primary Sjögren's syndrome when multiple histopathological features are included

Pers/media

Veni-beurzen voor zeven Groningse onderzoekers